Physician
Phelps Memorial Hospital Association
Phelps Memorial Hospital Association was paid $20.17M by Medicaid between Jan 2018 and Dec 2024, across 208 billing codes. Its largest line is 90853, Group psychotherapy (other than of a multiple-family group) — 17% of everything it billed.
33Billing provider infoPHELPS MEMORIAL HOSPITAL ASSOCIATION
SLEEPY HOLLOW, NY 10591
SLEEPY HOLLOW, NY 10591
33aNPI1720185267assigned 09/19/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$20.17M
24GClaims360,935
24DCodes billed208
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in New York
Rank by total paid#1 of 94
Median peer was paid$46K
This provider vs. median437×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,068 | $678K | |
| 2019 | 26,841 | $1.41M | |
| 2020 | 52,263 | $2.92M | |
| 2021 | 74,579 | $4.03M | |
| 2022 | 68,566 | $3.87M | |
| 2023 | 73,196 | $4.13M | |
| 2024incomplete | 56,422 | $3.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90853 | Group psychotherapy (other than of a multiple-family group) | 17% | 55,431 | 6,676 | $3.41M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 10,312 | 9,906 | $2.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.1% | 8,479 | 8,047 | $1.63M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.5% | 16,871 | 4,794 | $1.11M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.0% | 3,050 | 1,891 | $805K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.8% | 2,665 | 2,545 | $560K |
| H2001 | Rehabilitation program, per 1/2 day | 2.6% | 4,349 | 535 | $524K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.5% | 766 | 763 | $507K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 1,653 | 1,639 | $471K |
| 80053 | Comprehensive metabolic panel | 2.0% | 16,838 | 14,785 | $402K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 1,364 | 1,335 | $399K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 1,876 | 1,834 | $369K |
196 more codes
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.7% | 473 | $345K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 4,173 | $324K |
| 90832 | Psychotherapy session, about 30 minutes | 1.6% | 7,062 | $320K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.6% | 3,099 | $313K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.5% | 10,420 | $300K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 1.4% | 3,476 | $281K |
| 90834 | Psychotherapy session, about 45 minutes | 1.3% | 1,433 | $268K |
| H2036 | Alcohol and/or other drug treatment program, per diem | 1.3% | 1,973 | $259K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.2% | 3,469 | $248K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 28,457 | $241K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.1% | 1,203 | $227K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 215 | $192K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,439 | $189K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,604 | $181K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,106 | $159K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 261 | $155K |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 803 | $153K |
| 97161 | <1% | 1,386 | $151K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 756 | $142K |
| 87486 | <1% | 3,498 | $131K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,053 | $110K |
| 76641 | <1% | 1,507 | $110K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,249 | $105K |
| 86900 | <1% | 2,220 | $90K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,837 | $87K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 271 | $84K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,153 | $81K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 687 | $80K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,460 | $78K |
| Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml | <1% | 264 | $77K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,720 | $73K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 861 | $69K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,475 | $68K |
| 87581 | <1% | 3,498 | $67K | |
| 76536 | <1% | 926 | $65K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,122 | $64K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 211 | $60K |
| 59025 | Fetal non-stress test | <1% | 262 | $60K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,257 | $59K |
| 76830 | Ultrasound, transvaginal | <1% | 691 | $57K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,162 | $57K |
| 86901 | <1% | 2,219 | $55K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 3,583 | $52K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 267 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,786 | $52K |
| J3490 | Unclassified drugs | <1% | 3,698 | $51K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,845 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,300 | $50K |
| 86850 | <1% | 2,206 | $45K | |
| 82728 | <1% | 2,194 | $38K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,837 | $38K |
| 77065 | Tomosynthesis, mammo | <1% | 391 | $37K |
| 84439 | <1% | 2,120 | $36K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 686 | $35K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 3,095 | $34K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 36 | $34K |
| 97162 | <1% | 253 | $32K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 398 | $29K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,303 | $29K |
| 84403 | <1% | 919 | $28K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,058 | $27K |
| 77072 | <1% | 1,079 | $25K | |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 63 | $25K |
| 73564 | <1% | 555 | $25K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 42 | $23K |
| 77080 | <1% | 220 | $23K | |
| 82784 | <1% | 583 | $22K | |
| 77066 | Tomosynthesis, mammo | <1% | 231 | $22K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 873 | $21K |
| 82607 | <1% | 779 | $20K | |
| 80061 | Lipid panel | <1% | 965 | $19K |
| 87501 | <1% | 522 | $19K | |
| 83550 | <1% | 2,012 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,134 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,412 | $18K |
| 71250 | <1% | 147 | $18K | |
| 83540 | <1% | 2,023 | $18K | |
| 76642 | <1% | 418 | $17K | |
| 80321 | <1% | 2,371 | $16K | |
| 86140 | <1% | 2,490 | $14K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,437 | $13K |
| 85610 | <1% | 2,618 | $13K | |
| 99443 | <1% | 87 | $13K | |
| 84305 | <1% | 581 | $13K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 75 | $12K |
| 83615 | <1% | 1,971 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,021 | $11K |
| 83735 | <1% | 3,070 | $11K | |
| 85027 | <1% | 2,463 | $11K | |
| 82746 | <1% | 404 | $10K | |
| 83880 | <1% | 336 | $10K | |
| 85652 | <1% | 2,558 | $9K | |
| 88312 | <1% | 445 | $9K | |
| 84100 | <1% | 2,338 | $9K | |
| 80050 | General health panel | <1% | 38 | $9K |
| 83002 | <1% | 468 | $9K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 542 | $8K |
| 73630 | <1% | 456 | $8K | |
| 84550 | <1% | 1,622 | $8K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 144 | $8K |
| 86800 | <1% | 412 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 384 | $7K |
| 72141 | <1% | 13 | $7K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,134 | $7K |
| 83001 | <1% | 387 | $7K | |
| 94375 | <1% | 39 | $7K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 23 | $7K |
| 99442 | <1% | 52 | $7K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,794 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,489 | $7K |
| 81001 | <1% | 3,771 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 29 | $6K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 52 | $6K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 987 | $6K |
| 86769 | <1% | 242 | $6K | |
| 97014 | <1% | 293 | $6K | |
| 84146 | <1% | 293 | $6K | |
| 73610 | <1% | 285 | $6K | |
| 94060 | <1% | 24 | $6K | |
| 76770 | <1% | 39 | $6K | |
| 86376 | <1% | 329 | $6K | |
| 86334 | <1% | 221 | $6K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 29 | $5K |
| 82378 | <1% | 424 | $5K | |
| 84703 | <1% | 2,345 | $5K | |
| 73130 | <1% | 198 | $5K | |
| 85007 | <1% | 1,321 | $5K | |
| 82024 | <1% | 103 | $4K | |
| 82533 | <1% | 224 | $4K | |
| 84702 | <1% | 856 | $4K | |
| 73110 | <1% | 125 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,182 | $4K |
| 85730 | <1% | 1,234 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,562 | $3K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 774 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 12 | $3K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 27 | $3K |
| 99441 | <1% | 18 | $2K | |
| 83498 | <1% | 90 | $2K | |
| 84432 | <1% | 30 | $2K | |
| 85379 | <1% | 287 | $2K | |
| 80076 | <1% | 175 | $2K | |
| 94729 | <1% | 51 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 24 | $2K |
| 93017 | <1% | 76 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,416 | $2K |
| 83003 | <1% | 92 | $2K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 26 | $1K |
| 82157 | <1% | 50 | $1K | |
| 94200 | <1% | 26 | $1K | |
| 80320 | <1% | 391 | $1K | |
| C9399 | Unclassified drugs or biologicals | <1% | 12 | $1K |
| 97165 | <1% | 12 | $1K | |
| 84484 | <1% | 1,262 | $1K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 85 | $1K |
| 84165 | <1% | 85 | $995.76 | |
| 87631 | <1% | 16 | $986.55 | |
| 72082 | <1% | 61 | $873.37 | |
| 83690 | <1% | 1,697 | $862.96 | |
| 82962 | <1% | 564 | $854.74 | |
| 86003 | <1% | 40 | $819.34 | |
| 82627 | <1% | 40 | $791.65 | |
| 73030 | <1% | 55 | $791.38 | |
| 77062 | <1% | 26 | $758.38 | |
| 85045 | <1% | 123 | $752.26 | |
| 82570 | <1% | 67 | $724.12 | |
| 87634 | <1% | 135 | $720.96 | |
| 84436 | <1% | 447 | $709.38 | |
| 93971 | <1% | 12 | $584.71 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 301 | $557.46 |
| 76775 | <1% | 13 | $551.71 | |
| 72100 | <1% | 13 | $476.07 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 16 | $352.35 |
| 87070 | <1% | 189 | $345.86 | |
| 84480 | <1% | 57 | $345.37 | |
| 86300 | <1% | 15 | $290.81 | |
| 82626 | <1% | 13 | $266.24 | |
| 82232 | <1% | 12 | $258.70 | |
| 83605 | <1% | 298 | $239.55 | |
| 84140 | <1% | 12 | $220.67 | |
| 84156 | <1% | 41 | $200.25 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 84 | $187.29 |
| 86880 | <1% | 13 | $140.64 | |
| 83010 | <1% | 13 | $129.51 | |
| 81003 | <1% | 495 | $126.64 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 158 | $124.00 |
| 83525 | <1% | 12 | $101.79 | |
| 87186 | <1% | 13 | $98.45 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 15 | $65.97 |
| 84479 | <1% | 158 | $59.42 | |
| 82550 | <1% | 13 | $44.80 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 26 | $38.46 |
| 87430 | <1% | 75 | $25.68 | |
| 82947 | <1% | 17 | $7.34 | |
| 87040 | 0% | 19 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCUSACK, MICHELE (SENIOR VICE PRESIDENT & CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.